Amisulprid v léčbě schizofrenie

Warning

This publication doesn't include Institute of Computer Science. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Title in English	Amisulpride in the treatment of schizophrenia
Authors	USTOHAL Libor
Year of publication	2011
Type	Article in Periodical
Magazine / Source	Česká a slovenská neurologie a neurochirurgie
MU Faculty or unit	Central European Institute of Technology
Citation
Field	Psychiatry, sexuology
Keywords	amisulprid; schizophrenia; positive signs; negative signs
Description	Amisulpride is a second-generation antipsychotic agent acting as an antagonist of dopamine D2, D3 receptors. It works so-called biphasic in low doses causes an increase in dopamine neurotransmission, in higher doses, contrary to reduce it. It proved not only in treating the positive symptoms of schizophrenia, but a positive effect on negative and probably also on the affective (depressive) symptoms and cognitive dysfunction. Is effective as monotherapy, but there is evidence that it can be effective also in combination, namely with clozapine or olanzapine. It has few contraindications and a relatively low number of adverse effects is also well tolerated.
Related projects:	The internal organisation and neurobiological mechanisms of functional CNS systems under normal and pathological conditions.